tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Nanobiotix price target raised to EUR 13 from EUR 10 at H.C. Wainwright
The FlyNanobiotix price target raised to EUR 13 from EUR 10 at H.C. Wainwright
8d ago
NBTX
Nanobiotix price target raised to $14 from $9 at Leerink
PremiumThe Fly
Nanobiotix price target raised to $14 from $9 at Leerink
9d ago
NBTX
Nanobiotix announces new results from JNJ-1900 study
PremiumThe Fly
Nanobiotix announces new results from JNJ-1900 study
10d ago
JNJ
NBTX
Nanobiotix SA – ADR trading resumes
PremiumThe Fly
Nanobiotix SA – ADR trading resumes
2M ago
NBTX
Nanobiotix SA – ADR trading halted, volatility trading pause
PremiumThe Fly
Nanobiotix SA – ADR trading halted, volatility trading pause
2M ago
NBTX
Nanobiotix announces regulatory harmonization, new patent for JNJ-1900
PremiumThe FlyNanobiotix announces regulatory harmonization, new patent for JNJ-1900
3M ago
JNJ
NBTX
Promising Clinical Developments and Strategic Partnerships Propel Nanobiotix to a Buy Rating
Premium
Ratings
Promising Clinical Developments and Strategic Partnerships Propel Nanobiotix to a Buy Rating
4M ago
NBTX
Nanobiotix’s Strategic Advancements and Financial Strength Bolster Buy Rating
Premium
Ratings
Nanobiotix’s Strategic Advancements and Financial Strength Bolster Buy Rating
4M ago
NBTX
Nanobiotix’s NBTXR3: Promising Survival Benefits and Strategic Collaborations Justify Buy Rating
PremiumRatings
Nanobiotix’s NBTXR3: Promising Survival Benefits and Strategic Collaborations Justify Buy Rating
5M ago
NBTX
Nanobiotix SA’s Positive Earnings Call Highlights Strategic Growth
PremiumCompany Announcements
Nanobiotix SA’s Positive Earnings Call Highlights Strategic Growth
6M ago
Nanobiotix price target lowered to $8 from $12 at Guggenheim
PremiumThe Fly
Nanobiotix price target lowered to $8 from $12 at Guggenheim
6M ago
NBTX
Nanobiotix’s Promising Future: Buy Rating Backed by Data-Rich 2025 and Strategic Advancements
PremiumRatings
Nanobiotix’s Promising Future: Buy Rating Backed by Data-Rich 2025 and Strategic Advancements
6M ago
NBTX
Nanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
PremiumRatingsNanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
6M ago
NBTX
Positive Clinical Data and Strategic Partnerships Drive Buy Rating for Nanobiotix
Premium
Ratings
Positive Clinical Data and Strategic Partnerships Drive Buy Rating for Nanobiotix
6M ago
NBTX
Nanobiotix’s Strategic Partnership and Financial Stability Justify Buy Rating
Premium
Ratings
Nanobiotix’s Strategic Partnership and Financial Stability Justify Buy Rating
6M ago
NBTX
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
PremiumRatings
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
6M ago
NBTX
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
PremiumRatings
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
6M ago
NBTX
Nanobiotix amends global licensing agreement with Janssen Pharmaceutica
PremiumThe Fly
Nanobiotix amends global licensing agreement with Janssen Pharmaceutica
6M ago
JNJ
NBTX
Nanobiotix files $200M mixed securities shelf
PremiumThe Fly
Nanobiotix files $200M mixed securities shelf
7M ago
NBTX
Nanobiotix files to sell 5.62M ordinary shares for holders
PremiumThe FlyNanobiotix files to sell 5.62M ordinary shares for holders
7M ago
NBTX
Nanobiotix downgraded to Neutral from Buy at UBS
Premium
The Fly
Nanobiotix downgraded to Neutral from Buy at UBS
7M ago
NBTX
Nanobiotix doses first patient in CONVERGE study
Premium
The Fly
Nanobiotix doses first patient in CONVERGE study
8M ago
JNJ
NBTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >